- Q3 adjusted EPS: 71 cents.
- Q3 sales: $235 million.
Hinge Health reported Q3 adjusted EPS of 71 cents on $235 million in sales, above consensus of 58 cents and $224.8 million. Full-year sales guidance of $879 million-$881 million topped the $860.6 million consensus. Shares rose more than 2% after hours to $117.95.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.